Vaxcyte
PCVX
PCVX
197 hedge funds and large institutions have $5B invested in Vaxcyte in 2023 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 106 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
5% more funds holding
Funds holding: 187 → 197 (+10)
1.69% more ownership
Funds ownership: 105.08% → 106.77% (+1.7%)
75% less call options, than puts
Call options by funds: $6.1M | Put options by funds: $24.7M
Holders
197
Holding in Top 10
11
Calls
$6.1M
Puts
$24.7M
Top Buyers
| 1 | +$112M | |
| 2 | +$108M | |
| 3 | +$99M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$90.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$85.1M |
Top Sellers
| 1 | -$72.1M | |
| 2 | -$44.6M | |
| 3 | -$32M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$21.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$18.7M |